Affects of Once-daily Oral Administration of TZP-102 on the Treatment of Symptoms Associated With Diabetic Gastroparesis
Public ClinicalTrials.gov record NCT01452815. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Evaluation of the Efficacy and Safety of Once-Daily Administrations of TZP-102 for the Treatment of Symptoms Associated With Diabetic Gastroparesis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to test the safety and effectiveness of two dosage levels (10mg and 20mg) of TZP-102 compared to placebo (capsule that looks like the study drug but contains no active drug), administered once-daily for 12 weeks, in diabetic subjects with symptoms associated with gastroparesis.
Study identification
- NCT ID
- NCT01452815
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 201 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2011 (Type not available)
- Primary completion
- Nov 2012 (Actual)
- Completion
- Nov 2012 (Actual)
- Last update posted
- Apr 25, 2013
2011 – 2012
United States locations
- U.S. sites
- 31
- U.S. states
- 18
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Tranzyme Investigational Site | Huntsville | Alabama | 35801 | — |
| Tranzyme Investigational Site | Tucson | Arizona | 85710 | — |
| Tranzyme Investigational Site | Jonesboro | Arkansas | 72401 | — |
| Tranzyme Investigational Site | Little Rock | Arkansas | 72117 | — |
| Tranzyme Investigational Site | Long Beach | California | 90822 | — |
| Tranzyme Investigational Site | Stanford | California | 94305 | — |
| Tranzyme Investigational Site | Ventura | California | 93003 | — |
| Tranzyme Investigational Site | Hialeah | Florida | 33016 | — |
| Tranzyme Investigational Site | Inverness | Florida | 34450 | — |
| Tranzyme Investigational Site | Jacksonville | Florida | 32256 | — |
| Tranzyme Investigational Site | Miami | Florida | 33144 | — |
| Tranzyme Investigational Site | Miami | Florida | 33183 | — |
| Tranzyme Investigational Site | New Smyrna Beach | Florida | 32168 | — |
| Tranzyme Investigational Site | Port Orange | Florida | 32127 | — |
| Tranzyme Investigational Site | Oak Lawn | Illinois | 60453 | — |
| Tranzyme Investigational Site | Anderson | Indiana | 46016 | — |
| Tranzyme Investigational Site | Kansas City | Kansas | 66160 | — |
| Tranzyme Investigational Site | Monroe | Louisiana | 71201 | — |
| Tranzyme Investigational Site | Boston | Massachusetts | 02215 | — |
| Tranzyme Investigational Site | Mexico | Missouri | 65265 | — |
| Tranzyme Investigational Site | Fayetteville | North Carolina | 28304 | — |
| Tranzyme Investigational Site | Raleigh | North Carolina | 27612 | — |
| Tranzyme Investigational Site | Salisbury | North Carolina | 28144 | — |
| Tranzyme Investigational Site | Winston-Salem | North Carolina | 27103 | — |
| Tranzyme Investigational Site | Oklahoma City | Oklahoma | 73104 | — |
| Tranzyme Investigational Site | Portland | Oregon | 97210 | — |
| Tranzyme Investigational Site | Philadelphia | Pennsylvania | 19140 | — |
| Tranzyme Investigational Site | Jackson | Tennessee | 38305 | — |
| Tranzyme Investigational Site | El Paso | Texas | 79905 | — |
| Tranzyme Investigational Site | Houston | Texas | 77034 | — |
| Tranzyme Investigational Site | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 21 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01452815, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 25, 2013 · Synced Oct 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01452815 live on ClinicalTrials.gov.